Many people have been affected by rheumatic diseases for many years and have no choice but to choose appropriate methods for treatment. In fact, rheumatic pain is also pain in the joints accompanied by muscle pain, which is mainly caused by dysfunction of soft tissues and joints. Therefore, during rainy and cloudy days or exposure to cold air, there may be rheumatic pain.

1. Rheumatic diseases often affect joints, muscles, bones, and soft tissues, with symptoms such as pain, swelling, joint dysfunction, and fever being prominent. The primary goal of treatment for this group of diseases is to relieve symptoms, such as antipyretic, analgesic, and anti-inflammatory, so non-steroidal anti-inflammatory drugs, such as Futealin, Mobico, Losone, Tianxinliding, Celecoxib, and Valo, are often used. Moreover, the new non-steroidal anti-inflammatory drugs have good effects and high efficacy, significantly reducing side effects.

2. If rheumatic diseases are not treated correctly and reasonably, joint, muscle, and skeletal lesions can lead to functional impairment and deformity, leaving lifelong disabilities, affecting life and labor, and causing economic losses to individuals and society. From the perspective of the tissues invaded by rheumatic diseases, systemic lupus erythematosus, rheumatoid arthritis, systemic sclerosis, polymyositis, necrotizing vasculitis, and ankylosing spondylitis, which were previously known as connective tissue diseases, all have autoimmune disorders. Gouty arthritis has been clearly identified as a disorder of purine metabolism, leading to the precipitation of uric acid crystals in the joints, which remain in the joint cavity, affecting bones, and tendons. Therefore, the treatment of rheumatic diseases, in addition to symptomatic treatment to relieve symptoms, also requires etiological treatment. Autoimmune disorders require immunomodulation, such as the use of corticosteroids and immunosuppressants. Immunosuppressive therapy has made great progress, with the discovery of new drugs, such as Xiaoxi, Ainuo, Pavlin, and the development of new therapies, such as: ① For mild systemic lupus erythematosus, the combination therapy of low-dose prednisone, chloroquine, and mtx can significantly reduce side effects; ② For rheumatoid arthritis, combined therapy is used, including the combination of first-line and second-line drugs, and the combination of second-line drugs. ③ High-dose gamma globulin therapy for severe rheumatic diseases.

3. Biologic therapy and bone marrow transplantation have also been tried in clinical practice.